Quest Diagnostics (DGX) Reaffirms Dividend, Is The Stock Already Fully Valued?
Quest Diagnostics (DGX) Stock Could Be 31% Undervalued Following RESULTS Act Push
Quest Diagnostics (NYSE:DGX): A Quality Dividend Stock for Income Investors
Quest Diagnostics Declares Quarterly Cash Dividend
Quest Diagnostics to Speak at the 9th Annual Evercore Healthcare Conference
Quest Diagnostics to Speak at the Jefferies Global Healthcare Conference in London
IBD Stock Of The Day Quest Diagnostics Is Bucking The Medtech Malaise
Subu Ramachandran Expands Holdings With Quest Diagnostics Stock Options Worth $6K
Quest Diagnostics Upgraded After Strong Q3, While Also Announcing New Test For Alzheimer's
Quest Diagnostics (DGX) Stock Price Stalls After Strong Q3 Earnings
Quest Diagnostics (DGX) Backs At Home Cervical Cancer Screening
Quest Diagnostics (DGX) Stock Could Be Undervalued Despite Raised Full Year Guidance
Lab testing giant Quest Diagnostics confirms patients’ personal and health data was compromised during breach
Was Quest's 'Good Enough' Third Quarter Actually Good Enough?
What Quest Diagnostics (DGX) Said on Its Q3 Earnings Call
Quest Diagnostics (DGX) Q3 2026 Earnings Call Transcript
Quest Diagnostics Incorporated Q3 2026 Earnings Call Summary
DGX Q3 Earnings & Revenues Beat, '26 View Raised, Stock Down in Pre-Market
Why Quest's 'Good Enough' Third Quarter Wasn't Actually Enough
Quest Diagnostics Incorporated Reports Unauthorized Access to Quanum LSM System on October 21, 2026
Sign up for free to unlock this feature.
Creating your account...
Your account has been created. Redirecting...
Loading...
This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.